Unique ID issued by UMIN | UMIN000010999 |
---|---|
Receipt number | R000012849 |
Scientific Title | The efficacy of teneligliptin in diabetic patients on hemodialysis |
Date of disclosure of the study information | 2013/06/24 |
Last modified on | 2015/10/07 09:37:44 |
The efficacy of teneligliptin in diabetic patients on hemodialysis
The efficacy of teneligliptin in diabetic patients on hemodialysis
The efficacy of teneligliptin in diabetic patients on hemodialysis
The efficacy of teneligliptin in diabetic patients on hemodialysis
Japan |
Type2 diabetic patients on hemodialysis
Endocrinology and Metabolism | Nephrology |
Others
NO
To assess the efficacy and the safety of teneligliptin in type2 diabetic patients on hemodialysis
Safety,Efficacy
Confirmatory
Pragmatic
Phase IV
The primary end-point is postprandial plasma glucose, glycated albumin or HbA1c measurement three months after new, additional administration of teneligliptin and change from alogliptin in type 2 diabetic patients on hemodialysis.
Other laboratory data, hemodialytic indices and adverse events will be analyzed as well.
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1) Fresh cases for DPP-4 inhibitor:
Patients with poor glycemic control (HbA1c level exceeding 7.0% and/or glycated albumin level exceeding 21.0%) after two months on conventional therapy (dietary therapy alone or mitiglinide and/or alpha-glucosidase inhibitor).
2) Cases whose treatment is changed from other DPP-4 inhibitors:
Patients have been treated with alogliptin.
Patients having infectious diseases, thyroid disease, or malignant tumors. Patients being treated with steroids.
30
1st name | |
Middle name | |
Last name | Machiko Komatsu |
Kawashima Hospital
Department of diabetes mellitus
1-1-39 Kitasako, Tokushima, 770-8548, Japan
088-631-0110
machikomatsu@r7.dion.ne.jp
1st name | |
Middle name | |
Last name | Akiko Miyajima |
Kawashima Hospital
The general affairs division
1-1-39 Kitasako, Tokushima, 770-8548, Japan
088-631-0110
a.miyajima@khg.or.jp
Kawashima Hospital
None
Self funding
None
NO
2013 | Year | 06 | Month | 24 | Day |
Published
Completed
2013 | Year | 06 | Month | 03 | Day |
2013 | Year | 06 | Month | 24 | Day |
2016 | Year | 06 | Month | 30 | Day |
To evaluate the efficacy and the safety of teneligliptin in type 2 diabetic patients on hemodialysis
2013 | Year | 06 | Month | 19 | Day |
2015 | Year | 10 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012849
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |